Eli Lilly to sign $2bn deal for AI drug development with Hong Kong biotech

Chronological Source Flow
Back

AI Fusion Summary

Eli Lilly will invest $2 billion in a partnership with Hong Kong biotech to accelerate AI‑driven drug discovery, reflecting a broader trend of global pharma firms intensifying research efforts in China.
#Eli Lilly #AI drug development #Hong Kong biotech #$2bn investment #global pharma #China research #pharmaceutical partnership
29/03 14:00 ft.com
2 Πηγές

Eli Lilly to sign $2bn deal for AI drug development with Hong Kong biotech

Eli LillyAI drug developmentHong Kong biotech$2bn investmentglobal pharmaChina research
29/03 17:08 x.com

360withme: Hong Kong-listed AI drug discovery company Insilico Medicine and Eli Lilly sign a drug co-development deal worth up to $2.75B,...

Comments
Loading...
0